HR 1404, the CHAMPVA Children’s Care Protection Act of 2025, expands healthcare eligibility under the CHAMPVA program for children of veterans. It increases the maximum age for children to receive medical benefits from 21 to 26 years old, regardless of marital status. This change directly affects dependent children of veterans who were previously eligible until age 21, extending coverage through their mid-twenties. The policy amendment applies to medical care provided on or after the bill’s enactment date.
SJRES 82 is a joint resolution seeking to block a rule issued by the Department of Health and Human Services (HHS) regarding how the agency should follow the text of the Administrative Procedure Act (APA), a federal law governing how agencies create regulations. The rule, published in March 2025, was identified by the Government Accountability Office as a "rule" subject to the Congressional Review Act. If enacted, this resolution would void the HHS policy, preventing it from taking effect and requiring HHS to disregard this specific internal guideline. The bill directly affects HHS's rulemaking procedures by invalidating the policy statement on APA adherence.
HRES 966 is a ceremonial resolution passed by the U.S. House of Representatives to formally recognize California State Senator Monique Limón's historic appointment as the first Latina and first mother to serve as Senate President Pro Tempore. The resolution highlights her background as a first-generation college graduate, former educator, and long-time state legislator representing districts in Santa Barbara. It does not create new laws or policy changes; instead, it serves as a formal acknowledgment of her leadership and service to California. The resolution was submitted for her upcoming swearing-in on January 5, 2026.
The Data Care Act of 2025 requires online service providers (like social media platforms or apps that collect user data) to securely handle "individual identifying data," especially sensitive information like health details, biometrics, financial data, or precise location. It imposes three key duties: (1) reasonably securing data from breaches, (2) not misusing data to harm users or benefit themselves, and (3) restricting data sharing to third parties only with strict confidentiality contracts. The Federal Trade Commission and state attorneys general can enforce these rules through penalties for violations, with civil fines calculated based on the number of affected users or days of noncompliance. The law directly affects major digital platforms collecting user data and takes effect 180 days after enactment.
This bill requires the VA to provide telehealth services, mail-order pharmacy benefits, and mandatory beneficiary travel payments to veterans residing in the Freely Associated States (including Palau, the Marshall Islands, and Micronesia) within one year of enactment. It mandates quarterly reporting to Congress on implementation progress and associated costs. The law directly affects veterans in these Pacific Island nations by expanding access to critical healthcare and travel support services previously not uniformly guaranteed.
The NIH Clinical Trial Integrity Act requires sponsors of clinical trials approved by the National Institutes of Health (NIH) to set and meet specific goals for including participants from diverse racial, ethnic, age, and sex groups. This includes submitting detailed plans for recruitment and retention - such as using telemedicine for follow-ups or flexible scheduling - and reporting annual demographic data without personally identifiable information. Trials failing to meet these goals must develop a community-informed strategic plan to improve participation, which the NIH will publish. The bill also mandates a national awareness campaign to promote diverse trial participation and a study on reducing cost barriers for participants.
HCONRES 64 is a congressional resolution directing the President to withdraw U.S. military forces from any hostilities against Venezuela that lack explicit congressional authorization. It applies to ongoing military operations in Venezuela not approved by Congress through a declaration of war or specific law authorizing force. The resolution invokes the War Powers Resolution (50 U.S.C. 1544(c)), requiring the removal of troops within the timeframe specified by that law. This bill does not affect military actions already authorized by Congress but mandates the end of unapproved operations.
This bill establishes federal funding for research and development of alternative protein sources using biomanufacturing and bioprocessing technologies. It creates Centers of Excellence at agricultural institutions (including 1890 Land-Grant Universities), authorizes $50 million annually for food biomanufacturing facility grants, and provides $25 million yearly for workforce training programs. The bill directly affects research institutions, food biomanufacturing companies, and agricultural workforce development programs by providing grants for scaling production of plant-based and lab-grown proteins. It requires the USDA to develop a national strategy on protein security by 2026, focusing on supply chain resilience, job creation, and U.S. competitiveness in the global protein market. The legislation aims to diversify food systems and support domestic production of protein sources using underutilized biomass.
The PROTECT for Rare Act (S 3551) requires Medicare, Medicaid, and private health insurers to establish an expedited appeal process for coverage denials of drugs treating rare diseases or conditions affecting 200,000 or fewer U.S. individuals. It expands coverage criteria by allowing insurers to consider peer-reviewed medical literature and clinical guidelines - not just FDA-approved labeling - as valid justification for treatment, while excluding uses listed as contraindicated in approved drug labeling or medical references. The law applies to all covered drugs used for rare conditions and takes effect for coverage decisions starting January 1, 2027. This directly affects patients with rare diseases, healthcare providers seeking coverage approvals, and insurers managing drug benefit denials.
The Clean Competition Act imposes a carbon intensity charge on covered primary goods produced domestically or imported into the U.S., calculated based on how much a facility's carbon intensity exceeds industry benchmarks. The charge starts at $60 per metric ton of CO2-e in 2026 and increases annually, determined by (excess carbon intensity) x (quantity of goods) x (cost of pollution). The bill includes provisions for rebates on exports, reductions for emissions captured directly from the air, and mechanisms to support decarbonization through investments in clean technology. It also establishes "carbon clubs" for international cooperation on climate policies, affecting manufacturers in specific energy-intensive industries and importers of covered goods.
S 3540, the LISTOS Act of 2025, requires major online platforms (those with 10 million+ U.S. monthly active users) to ensure consistent content moderation across languages where they generate revenue. It mandates annual public reports detailing staffing levels, language proficiency, translation practices, automated system performance, and moderation outcomes for each monetized language. Platforms must also make reporting tools and policies accessible in all supported languages. Enforcement falls to the Federal Trade Commission and state attorneys general, with penalties for noncompliance.
This bill prohibits the use of federal funds to implement, administer, or enforce the December 11, 2025, executive order on national AI policy. It directly affects federal agencies that would otherwise carry out the executive order's requirements using taxpayer money. The key mechanism is a funding restriction, preventing federal resources from supporting the national AI policy framework outlined in the executive order.
